BFC Planning’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
BFC Planning's BBIO Position: Q3 2026 in Review
BFC Planning increased its BridgeBio Pharma (BBIO) stake by 62% in Q3 2026, buying an estimated $3.27K and bringing the position to 110 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2529.
BFC Planning first reported a position in BBIO in Q4 2025 and has held it in 4 quarters since. 354 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- BFC Planning held 110 shares of BridgeBio Pharma worth $7.24K as of Q3 2026.
- BFC Planning bought 42 BridgeBio Pharma shares in Q3 2026, an estimated $3.27K.
- BridgeBio Pharma made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2529 holding.
- BFC Planning first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 4 quarters since.
- 354 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.